| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
| 04/17/2003 | CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
| 04/17/2003 | CA2462892A1 Human 3 relaxin |
| 04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | CA2462806A1 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide |
| 04/17/2003 | CA2462801A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists |
| 04/17/2003 | CA2462582A1 Adjuvants for nucleic acid vaccines |
| 04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | CA2462291A1 Methods and compositions for treating dermal lesions |
| 04/17/2003 | CA2461900A1 Leukocyte inactivation module |
| 04/17/2003 | CA2461343A1 Mammalian c-type lectins |
| 04/17/2003 | CA2461064A1 Inhibition of stat-1 |
| 04/17/2003 | CA2460480A1 Molecules for disease detection and treatment |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458645A1 Intracellular signaling molecules |
| 04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |
| 04/16/2003 | EP1302542A1 Novel physiologically active peptide and use thereof |
| 04/16/2003 | EP1302541A1 Receptor protein specifically recognizing bacterial dna |
| 04/16/2003 | EP1302536A2 Embryonic stem cells and neural progenitor cells derived therefrom |
| 04/16/2003 | EP1302476A1 Reduced fk228 and use thereof |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1302461A1 Tnf-alpha production inhibitors |
| 04/16/2003 | EP1301637A2 Dna vaccines encoding hiv accessory proteins |
| 04/16/2003 | EP1301616A2 Bicistronic influenza viruses comprising two genes in tandem |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301535A2 G-protein coupled receptors |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301522A1 Novel compounds and methods |
| 04/16/2003 | EP1301516A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 04/16/2003 | EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
| 04/16/2003 | EP1301495A2 Inhibitors of copper-containing amine oxidases |
| 04/16/2003 | EP1301490A2 5-substituted 2-aryl-4-pyrimidinones |
| 04/16/2003 | EP1301488A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 04/16/2003 | EP1301481A1 Pyrrole derivatives for treating aids |
| 04/16/2003 | EP1301208A1 Vaccine |
| 04/16/2003 | EP1301203A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 04/16/2003 | EP1301202A2 Genetically-engineered mhc molecules |
| 04/16/2003 | EP1301193A1 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
| 04/16/2003 | EP1301191A1 Potent immunostimulants from microalgae |
| 04/16/2003 | EP1301173A1 A medicinal aerosol formulation |
| 04/16/2003 | EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/16/2003 | EP1150697B1 High molecular weight extracts of convolvulus arvensis (field bindweed) |
| 04/16/2003 | EP1103270B1 Treatment of autoimmune diseases in mammals |
| 04/16/2003 | EP1083901B1 Efavirenz compressed tablet formulation |
| 04/16/2003 | EP1054667B1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents |
| 04/16/2003 | EP1053240B1 Glucocorticoid-selective antiinflammatory agents |
| 04/16/2003 | EP1051156B1 Pharmaceutical compositions |
| 04/16/2003 | EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential |
| 04/16/2003 | EP0942896B1 Substituted phenols and thiophenols useful as antioxidant agents |
| 04/16/2003 | EP0921810B1 Reduction of the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
| 04/16/2003 | EP0920322B1 Use of modified autologous blood for the treatment of autoimmune diseases |
| 04/16/2003 | EP0869945B1 Catechol diethers derivatives useful as pharmaceutical agents |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 04/16/2003 | EP0648127B1 Type i surface antigens associated with staphylococcus epidermidis |
| 04/16/2003 | EP0605442B1 Recombinant antibodies for human therapy |
| 04/16/2003 | CN1411461A Thienopyridine derivatives and their preparing process and use |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 04/16/2003 | CN1411436A Hydroxamic acid derivative as inhibitor of formation of soluble human CD23 |
| 04/16/2003 | CN1411386A Treatment of subnormal bone mineral density |
| 04/16/2003 | CN1411380A Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
| 04/16/2003 | CN1410101A Medicine for antiimmune disorder and its production technology |
| 04/16/2003 | CN1410100A Medicine for regulating immunity and its production method |
| 04/16/2003 | CN1410091A External use medicine for treating allergic nasitis and preparing process thereof |
| 04/16/2003 | CN1410054A II type collagen water soluble dispersion composition, its preparation method and application |
| 04/16/2003 | CN1105728C Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105716C Benzimidazole derivatives with antihistaminic activity |
| 04/16/2003 | CN1105705C Process for preparing heterocyclic amide derivative with specific physical status |
| 04/15/2003 | US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548655 Interleukin-4 receptors |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548550 Treating eosinophilic granuloma in cats |
| 04/15/2003 | US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548479 Fused bicyclic peptides are administered to an animal to inhibit the proliferation of CD4 T-cells |
| 04/15/2003 | US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds |
| 04/15/2003 | US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease |
| 04/15/2003 | US6548075 Mixture containing polyglucans |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548055 Activation cell in immunology system |
| 04/15/2003 | CA2078466C Novel 3-cycloalkyl-propen-2-amide derivatives, tautomers and salts thereof, process for preparing the same and their use as drugs, compositions containing them |